JanOne Inc. is a biopharmaceutical company that focuses on developing effective non-opioid therapies to treat pain and addiction. With three segments, the company's lead product candidate is JAN101, an oral and sustained release pharmaceutical composition of sodium nitrite used to treat pain in patients with diabetes. The company also provides utility services and wireless modules.